Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
Reset 

Epitopea Awarded Grant from Innovate UK’s Cancer Therapeutics Programme

Read more ››
By: GlobeNewswire - 12 Sep 2024

SOPHiA GENETICS Announces Updates on SOPHiA UNITY at ESMO 2024

Read more ››
By: PR Newswire Association LLC. - 12 Sep 2024
Related companies:  SOPHiA GENETICS SA

Berlin Heals Strengthens Executive Leadership Team

Read more ››
By: PR Newswire Association LLC. - 12 Sep 2024

Ryvu Therapeutics Reports 2024 Half-Year Financial Results and Provides Corporate Update

Read more ››
By: PR Newswire Association LLC. - 12 Sep 2024

Biocomposites to distribute its NanoBone® product range in the UK

Read more ››
By: PR Newswire Association LLC. - 12 Sep 2024
Related companies:  Biocomposites Ltd.

POLYTECH Expands Portfolio with New Opticon® Plus Breast Implant

Read more ››
By: PR Newswire Association LLC. - 12 Sep 2024

Qritive Joins Forces with Roche to Redefine Global Cancer Diagnostics with AI

Read more ››
By: PR Newswire Association LLC. - 12 Sep 2024

BMC at ERS 2024: Exploring the Future of Sleep and Respiratory Health

Read more ››
By: PR Newswire Association LLC. - 12 Sep 2024

Santhera Announces Half-Year 2024 Financial Results and Provides Corporate Update

Read more ››
By: GlobeNewswire - 12 Sep 2024
Related companies:  Santhera Pharmaceuticals (Schweiz) AG

Vivoryon Therapeutics N.V. Reports H1 2024 Progress Marked by Compelling Kidney Function Data and Execution of Strategy to Advance Varoglutamstat in Kidney Disease

Read more ››
By: GlobeNewswire - 12 Sep 2024
Related companies:  Vivoryon Therapeutics N.V.

Genespire appoints Karen Aiach-Pignet as Chief Executive Officer

Read more ››
By: GlobeNewswire - 12 Sep 2024
Related companies:  GeneSpire Srl

Press Release: Sanofi, RadioMedix, and Orano Med announce licensing agreement on next-generation radioligand medicine for rare cancers

Read more ››
By: GlobeNewswire - 12 Sep 2024
Related companies:  Sanofi SA

Syra Health Announces Pricing of $2.1 Million Public Offering

Read more ››
By: PR Newswire Association LLC. - 12 Sep 2024
Related companies:  Syra Health Corp.

Kedrion Biopharma's Focus on Advancing Patient Care in Rare Disease to be Showcased at NBDF Conference 2024

Read more ››
By: PR Newswire Association LLC. - 12 Sep 2024
Related companies:  Kedrion Biopharma Inc.

NCCN Commits to Sharing Award-Winning Resources for People with Cancer in Spanish and Other Languages

Read more ››
By: PR Newswire Association LLC. - 12 Sep 2024

BIOVAXYS ANNOUNCES CLOSING OF THIRD TRANCHE OF PRIVATE PLACEMENT

Read more ››
By: PR Newswire Association LLC. - 12 Sep 2024
Related companies:  BioVaxys Technology Corporation

RNA-Based Therapeutics Market to Grow by USD 1.27 Billion (2024-2028) Due to Increased Investment and Funding, AI Trends Impacting Revenue - Technavio

Read more ››
By: PR Newswire Association LLC. - 12 Sep 2024

TREMFYA® (guselkumab) receives U.S. FDA approval for adults with moderately to severely active ulcerative colitis, strengthening Johnson & Johnson's leadership in inflammatory bowel disease

Read more ››
By: PR Newswire Association LLC. - 12 Sep 2024
Related companies:  Johnson & Johnson, Inc.

Head-to-head Superiority over Dulaglutide: Innovent's Phase 3 Clinical Trial DREAMS-2 of Mazdutide in Chinese Patients with Type 2 Diabetes were Orally Presented at EASD 2024

Read more ››
By: PR Newswire Association LLC. - 12 Sep 2024
Related companies:  Innovent Biologics (USA), Inc.

UPDATE - Glass House Brands to Host Analyst & Institutional Investor Day on September 12, 2024 at the SoCal Farm in Camarillo, California

Read more ››
By: GlobeNewswire - 11 Sep 2024
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
to the top ↑